Considering Biological and Biosimilar Medicines to Treat Rheumatic Diseases – Making the Right Call - Certificate of Completion

Duration

1 hr

Profession

Pharmacy

# of Credits

2.0

Accreditation

Certificate of Completion

Expiry Date

2020-04-04

Rheumatoid arthritis (RA) is a chronic inflammatory disease characterised by joint swelling, joint tenderness and destruction of synovial joints. The primary goal in treating patients with RA is to maximise long-term quality of life. In recent years, treat-to-target recommendations have been formulated for the management of RA. These targets include either remission (the absence of symptoms or signs of inflammatory disease activity) or low-level disease activity.

This interactive online learning activity is valued at 1 Hour(s) of continuing education.

Adjunct Associate Professor Deborah Rigby
(BPharm, GradDipClinPharm, AdvDipNutrPharm, AdvPracPharm,
AACPA, FPS, FASCP, FACP, FSHP, FAICD
Adjunct Associate Professor, University of Queensland,
Adjunct Associate Professor, Queensland University of Technology
Brisbane, Queensland)

Après avoir réussi ce programme, le participant sera en mesure de :

  1. expliquer les troubles gastro-intestinaux fonctionnels et donner des exemples courants;
  2. identifier les symptômes qui peuvent être traités avec des modifications du mode de vie et/ou du régime alimentaire et/ou à l’aide d’antispasmodiques en vente libre par rapport aux symptômes alarmants qui nécessitent que le patient soit dirigé vers un spécialiste;
  3. fournir des conseils aux patients dans les domaines de la nutrition et du mode de vie;
  4. décrire les options de traitement.


Related Courses